Open original FDA record ↗Recall record
- FDA identifier
- Z-1438-2017
- Company in FDA record
- Abbott Laboratories
- FDA classification date
- Mar 9, 2017
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The Pump Relay Printed Circuit Board Assembly (PCBA) used in the CELL-DYN Ruby instrument may prematurely fail and lead to instrument stoppage
Source facts
- Action
- Product correction letters were sent to all affected customers on February 13, 2017 by traceable method. Letters provided information on the reason for the correction with all affected serial numbers listed. Abbott will be contacting each location to schedule replacement of the PCBA Pump Relay Board. Update: five additional serial numbers were added. Correction letters were sent to new consignees - 3 in Brazil and 2 in Mexico.
- Initiated
- 2017-02-13
- Root cause
- Nonconforming Material/Component
- Terminated
- 2018-03-06
- Distribution
- US and Afghanistan, Brazil, Egypt, Tanzania, Hungary, Iraq, Kenya, Netherlands, Russia, Romania Vietnam, , United Kingdom, Saudi Arabia, Philippines, Lebanon, Mexico, Japan, Jordan, India, Indonesia, Turkey, UAE, Gaza & Jericho, Germany, Bulgaria, Chile, Argentina, Luxembourg.
- Recall number
- Z-1438-2017
- Recall status
- Terminated
- CDRH record ID
- 153336
- FDA classified
- 2017-03-09
- Recall event number
- 76481